C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.750
-0.080 (-2.83%)
At close: Apr 28, 2026, 4:00 PM EDT
2.760
+0.010 (0.36%)
After-hours: Apr 28, 2026, 7:40 PM EDT
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $268.34 million as of April 28, 2026. Its market cap has increased by 212.40% in one year.
Market Cap
268.34M
Enterprise Value
29.76M
1-Year Change
212.40%
Ranking
Category
Stock Price
$2.75
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $268.34M, a decrease of -65.27%. That is a compound annual growth rate of -17.30%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coherus Oncology | 283.76M |
| Editas Medicine | 282.85M |
| Minerva Neurosciences | 281.90M |
| AC Immune | 281.73M |
| NovaBridge Biosciences | 281.03M |
| Compugen | 276.10M |
| Cybin | 270.19M |
| Protara Therapeutics | 269.88M |